Page last updated: 2024-11-02

oxidopamine and Decerebrate Posturing

oxidopamine has been researched along with Decerebrate Posturing in 12 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
"No protection against drug-induced arrhythmia or death was afforded by this procedure."5.27Does chlorpromazine produce cardiac arrhythmia via the central nervous system? ( Lathers, CM; Lipka, LJ; Roberts, J, 1988)
"No protection against drug-induced arrhythmia or death was afforded by this procedure."1.27Does chlorpromazine produce cardiac arrhythmia via the central nervous system? ( Lathers, CM; Lipka, LJ; Roberts, J, 1988)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19906 (50.00)18.7374
1990's5 (41.67)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luquin, N1
Mitrofanis, J1
Van der Werf, JF2
Sebens, JB2
Korf, J2
Van het Schip, F1
Kolibal-Pegher, S1
Edwards, DJ1
Meyers-Schoy, SA1
Vollmer, RR2
Moorman, SJ1
Whalen, LR1
Kobayashi, H1
Hasegawa, Y1
Ono, H1
Ono, M1
Satoh, T1
Konkol, RJ1
Wesselmann, U1
Karpus, WJ1
Leo, GL1
Killen, JA1
Roerig, DL1
Fluharty, SJ1
Meyers, SA1
McCann, MJ1
Zigmond, MJ1
Stricker, EM1
Fozard, JR1
Palfreyman, MG1
Robin, M1
Zreika, M1
Lai, YY1
Siegel, JM1
Wilson, WJ1
Lipka, LJ1
Lathers, CM1
Roberts, J1

Other Studies

12 other studies available for oxidopamine and Decerebrate Posturing

ArticleYear
Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
    Parkinsonism & related disorders, 2008, Volume: 14, Issue:3

    Topics: Adrenergic Agents; Animals; Cell Count; Cell Death; Decerebrate State; Dopamine; Male; Neurons; Oxid

2008
In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.
    European journal of pharmacology, 1984, Jul-13, Volume: 102, Issue:2

    Topics: Animals; Apomorphine; Cerebellum; Corpus Striatum; Decerebrate State; Hydroxydopamines; Kainic Acid;

1984
Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    European journal of pharmacology, 1984, Jul-20, Volume: 102, Issue:3-4

    Topics: Animals; Butyrophenones; Cerebral Cortex; Corpus Striatum; Decerebrate State; Hydroxydopamines; Kain

1984
Adrenal medullary adaptations and cardiovascular regulation after 6-hydroxydopamine treatment in rats.
    Journal of the autonomic nervous system, 1994, Volume: 48, Issue:2

    Topics: Adrenal Medulla; Adrenalectomy; Animals; Behavior, Animal; Blood Pressure; Decerebrate State; Dopami

1994
A model system to determine the effects of specific neurotransmitters on segmental reflexes in the spinal cord of the rat.
    Journal of neuroscience methods, 1993, Volume: 46, Issue:1

    Topics: Animals; Clonidine; Decerebrate State; Dopamine; Electromyography; Electrophysiology; Female; Hindli

1993
Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems.
    European journal of pharmacology, 1996, Sep-05, Volume: 311, Issue:1

    Topics: Adrenergic alpha-2 Receptor Antagonists; Amitriptyline; Animals; Decerebrate State; Fenclonine; Male

1996
Pharmacological studies on lappaconitine: possible interaction with endogenous noradrenergic and serotonergic pathways to induce antinociception.
    Japanese journal of pharmacology, 1992, Volume: 58, Issue:3

    Topics: 5,7-Dihydroxytryptamine; Aconitine; Afferent Pathways; Analgesics; Animals; Decerebrate State; Injec

1992
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine.
    Journal of neuroimmunology, 1990, Volume: 26, Issue:1

    Topics: Animals; Body Weight; Brain; Catecholamines; Cerebral Ventricles; Cisterna Magna; Decerebrate State;

1990
Recovery of chronotropic responsiveness after systemic 6-hydroxydopamine treatment: studies in the pithed rat.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:2

    Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Blood Pressure; Catecholamines; Decerebrate State;

1987
Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    British journal of pharmacology, 1986, Volume: 87, Issue:1

    Topics: Allylamine; Amines; Animals; Blood Pressure; Brain; Decerebrate State; Dose-Response Relationship, D

1986
Effect of blood pressure on medial medulla-induced muscle atonia.
    The American journal of physiology, 1987, Volume: 252, Issue:6 Pt 2

    Topics: Adrenal Medulla; Animals; Blood Pressure; Brain Stem; Carotid Arteries; Cats; Decerebrate State; Den

1987
Does chlorpromazine produce cardiac arrhythmia via the central nervous system?
    Journal of clinical pharmacology, 1988, Volume: 28, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Central Nervous System; Chlorpromazine; Decereb

1988